Smoothie King introduced a GLP-1 Support Menu designed for consumers using weight-loss medications
Microorganisms, 13 (2), 305
Wegovy and Rybelsus are now available in pill form
No Ozempic lawsuit settlement has been reached at this stage of the litigation, and any projected compensation ranges remain estimates based on comparable pharmaceutical mass tort cases involving severe gastrointestinal injuries and permanent vision loss
FDA's April 30, 2026 Proposal On April 30, 2026, the FDA announced a proposal to exclude semaglutide, tirzepatide, and liraglutide from the 503B Bulks List, finding no clinical need for outsourcing facilities to compound these drugs from bulk drug substances when FDA-approved versions are available
Now, microdosing is part of the GLP-1 lexicon, even if not everyone agrees on its exact definition